Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

En-CPhI.CNNovember 18, 2019

Tag: 3SBio , Verseau , VTX-0811 , Immuno-Oncology

PharmaSources Customer Service